Your browser doesn't support javascript.
loading
Understanding patients' care barriers in the treatment of venous thromboembolism.
Pulleyn, Timothy; Kim, Kibum; Witt, Daniel M; Feehan, Michael; Munger, Mark A.
Afiliación
  • Pulleyn T; Department of Pharmacotherapy, University of Utah, 30 South, 2000 East, Rm #4323, Salt Lake City, UT, 84112-5820, USA.
  • Kim K; Department of Pharmacotherapy, University of Utah, 30 South, 2000 East, Rm #4323, Salt Lake City, UT, 84112-5820, USA.
  • Witt DM; Department of Pharmacotherapy, University of Utah, 30 South, 2000 East, Rm #4323, Salt Lake City, UT, 84112-5820, USA. dan.witt@pharm.utah.edu.
  • Feehan M; Kantar LLC, San Francisco, CA, USA.
  • Munger MA; Department of Pharmacotherapy, University of Utah, 30 South, 2000 East, Rm #4323, Salt Lake City, UT, 84112-5820, USA.
J Thromb Thrombolysis ; 48(1): 35-41, 2019 Jul.
Article en En | MEDLINE | ID: mdl-31102162
Venous thromboembolism (VTE) is a major health care problem. There are common barriers to quality healthcare but are these barriers the same for VTE patients? A national online survey was administered to adults who had experienced a recent VTE event. The survey assessed perceptions of VTE care barriers: (1) Difficulty to meet healthcare costs related to VTE care; (2) difficulty to meet costs for VTE prescription medications; (3) difficulty with transportation to get VTE care; and (4) the degree of support of others needed to get VTE care. Each question was correlated with patient demographics including income level, place of residence, current work status, and health insurance; care related patient harms experienced with the VTE episode; number of lifetime VTE events; beliefs concerning VTE outcomes, and oral anticoagulant therapy type. Logistic regression analysis was used to determine the effect of independent variables on barriers to VTE care. Approximately 30% of VTE patients reported at least one significant barrier to VTE care. Patients rated healthcare costs and VTE prescription medication costs mildly difficult. The odds of reporting barriers were positively associated with the number of DVTs experienced in the previous 2 years. VTE-related depression was also moderately associated with increased odds of reporting significant VTE care barriers. Nearly 1 in 3 VTE sufferers reported significant barriers to VTE care, with healthcare costs and VTE medication costs being the most common. Efforts to identify patients who may experience barriers should be sought early in care.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de la Atención de Salud / Encuestas y Cuestionarios / Costos de la Atención en Salud / Tromboembolia Venosa Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: J Thromb Thrombolysis Asunto de la revista: ANGIOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de la Atención de Salud / Encuestas y Cuestionarios / Costos de la Atención en Salud / Tromboembolia Venosa Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: J Thromb Thrombolysis Asunto de la revista: ANGIOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos